← back to the front page

🗞️ Story file #1649

FDA requires new eye risk warning on GLP-1 drugs

Nov 9, 5 PM ET to Nov 10, 10 AM ET

📰 read it at: HuffPost ABC News AP CBS News CNBC CNN NBC News The Independent The Washington Post MarketWatch News Nation The Hill Fox Business The Epoch Times The Washington Times New York Post Newsmax Townhall

👣 How this story traveled: from the front pages that broke it, out through TV, radio and the shows, into what people retold and what fact-checkers examined, and on into the saga it is part of. Everything here is matched to the story by our tools, so a link can be wrong; the trackers' pages say how each is made.

  1. Nov 9, 5 PM ETfirst on a front page: ABC News
  2. Nov 9, 7 PM ETfirst on the radio: NPR News Now
  3. Nov 9, 8 PM ETfirst on TV: MSNOW
  4. Nov 10, 5 AM ETretold online by 11 people
  5. Nov 10, 10 AM ETpeak: on 18 front pages

📰 Spread

the front pages that ran it, hour by hour

Nov 9, 6 PM9 PMNov 103 AM6 AM9 AM918leftcenterright
Front pages carrying it at each hourly run, Nov 9, 5 PM to Nov 10, 10 AM ET (peak 18), by the outlets' lean: left · center · right
Nov 9, 6 PMNov 106 AMCNNCNNCNN, Nov 9, 12:03 PM ET: US FDA orders new eye risk warnings for Ozempic, ZepboundMarketWatchMarketWatchMarketWatch, Nov 9, 1:03 PM ET: Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision lossNBC NewsNBC NewsNBC News, Nov 9, 2:03 PM ET: FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindnessNewsmaxNewsmaxNewsmax, Nov 9, 3:03 PM ET: FDA Orders New Eye Risk Warnings for GLP-1sNew York PostNew York PostNew York Post, Nov 9, 4:02 PM ET: GLP-1 drugs must have new warning label over incurable blindness condition, says FDAThe Epoch TimesThe Epoch TimesThe Epoch Times, Nov 9, 4:02 PM ET: FDA Mandates New Eye Risk Warning on GLP-1 DrugsABC NewsABC NewsABC News, Nov 9, 5:02 PM ET: FDA orders new warning on GLP-1 drugs over rare eye conditionABC News, Nov 9, 6:02 PM ET: Taking Ozempic or Wegovy? What to know about the FDA's new eye warningAPAPAP, Nov 9, 5:02 PM ET: FDA adds rare vision-loss warning to popular GLP-1 drugsThe Washington PostThe Washington PostThe Washington Post, Nov 9, 5:02 PM ET: FDA tells GLP-1 makers to warn of potential vision loss side effectThe Washington Post, Nov 9, 9:02 PM ET: FDA tells GLP-1 makers to warn of potential vision loss side effect - The Washington PostThe HillThe HillThe Hill, Nov 9, 6:02 PM ET: FDA warns of rare ‘eye stroke’ risk from GLP-1 drugsCBS NewsCBS NewsCBS News, Nov 9, 8:02 PM ET: FDA warns of rare vision-loss side effect from GLP-1 drugsTownhallTownhallTownhall, Nov 9, 8:02 PM ET: FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye ConditionThe IndependentThe IndependentThe Independent, Nov 9, 9:02 PM ET: FDA to require GLP-1 makers to add major change to warning labelsHuffPostHuffPostHuffPost, Nov 9, 10:02 PM ET: FDA Adds Rare Vision-loss Warning To Popular GLP-1 DrugsHuffPost, Nov 10, 8:02 AM ET: FDA Adds Rare Vision-Loss Warning To Popular GLP-1 DrugsNews NationNews NationNews Nation, Nov 9, 11:02 PM ET: FDA requires safety label changes for GLP-1s over risk for eye conditionCNBCCNBCCNBC, Nov 10, 3:02 AM ET: FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, ZepboundFox BusinessFox BusinessFox Business, Nov 10, 9:02 AM ET: FDA adds rare warning to GLP-1 drugs used by millionsFox Business, Nov 10, 10:02 AM ET: FDA adds warning to GLP-1 drugs used by millions over rare riskThe Washington TimesThe Washington TimesThe Washington Times, Nov 10, 10:02 AM ET: FDA warning: Ozempic, other weight-loss drugs can cause vision loss📺 TVMSNOW, 8:20 PM ET: CALQUENCE can cause serious side effects, which may lead to deathFox News, 10:28 PM ET: The mechanism of action is not fully understoodMSNOW, 11:17 PM ET: CALQUENCE can cause serious side effects, which may lead to deathFox News, 5:09 AM ET: Not approved for elderly patients with dementia-related psychosis due to increased risk of death or strokeFox News, 5:48 AM ET: Not approved for elderly patients with dementia-related psychosis due to increased risk of death or strokeFox News, 5:53 AM ET: HEALTH TIP TUESDAY. DOCTOR RANKS TODAY'S HOTTEST WELLNESS TRENDSFox News, 5:54 AM ET: HEALTH TIP TUESDAY. DOCTOR RANKS TODAY'S HOTTEST WELLNESS TRENDSFox News, 5:55 AM ET: HEALTH TIP TUESDAY. DOCTOR RANKS TODAY'S HOTTEST WELLNESS TRENDSFox News, 5:55 AM ET: HEALTH TIP TUESDAY. DOCTOR RANKS TODAY'S HOTTEST WELLNESS TRENDSFox News, 5:55 AM ET: DOCTOR REVEALS WHICH HEALTH TRENDS REALLY WORKFox News, 5:56 AM ET: DOCTOR REVEALS WHICH HEALTH TRENDS REALLY WORKFox News, 5:57 AM ET: DOCTOR REVEALS WHICH HEALTH TRENDS REALLY WORKCNN, 6:45 AM ET: Most common side effects include respiratory and gastrointestinal, urinary tract infections, headache, and injection site reactions (efgartigimod alfa and I)MSNOW, 6:47 AM ET: In clinical trials, many had itch relief andCNN, 7:21 AM ET: Liver problems leading to hospitalization may occur when treated for Crohn's📻 radioNPR News Now, Nov 10, 5:09 AM ET: story 9 of 9NPR News Now, Nov 10, 2:09 AM ET: story 8 of 8NPR News Now, Nov 9, 11:09 PM ET: story 3 of 6NPR News Now, Nov 9, 7:09 PM ET: story 3 of 5🧶 online🧶found retold online (the day's report)
Who carried it and when: each outlet in the order it picked the story up, a bar for each headline from when we first saw it on the front page to when we last did, in the outlet's lean color (dashed: not rated); a dot marks a new headline, and a headline swapped for a new one between our hourly looks runs on to it. A gap means a look found the story gone from that front page. Beneath, its captions on TV, the radio newscasts that carried it (bigger: the lead) and when people were found retelling it. Hover for details.

📡 Wire copy

1 outlet ran the AP headline nearly word for word

HuffPost

💬 Quoted

  1. “eye stroke”1

phrases its headlines put in quotation marks; the bar is how many outlets did

📌 Linked by aggregators

2 Drudge Report · Google News

aggregators linking to it from their front page (they don't count as outlets covering it)

✏️ 4 outlets ran more than one headline on it (reworded, or a follow-up)
  • ABC News (2 wordings): “FDA orders new warning on GLP-1 drugs over rare eye condition” → “Taking Ozempic or Wegovy? What to know about the FDA's new eye warning”
  • Fox Business (2 wordings): “FDA adds rare warning to GLP-1 drugs used by millions” → “FDA adds warning to GLP-1 drugs used by millions over rare risk”
  • HuffPost (2 wordings): “FDA Adds Rare Vision-loss Warning To Popular GLP-1 Drugs” → “FDA Adds Rare Vision-Loss Warning To Popular GLP-1 Drugs”
  • The Washington Post (2 wordings): “FDA tells GLP-1 makers to warn of potential vision loss side effect” → “FDA tells GLP-1 makers to warn of potential vision loss side effect - The Washington Post”
📰 Every outlet's headline 18left to right by AllSides rating

📡 Broadcast

TV, radio, and the shows that talked about it

📺 On TV

minutes its captions were on screen, by channel; the disc is the network's lean

  1. 🐘 Fox News 4 min
  2. 🫏 MSNOW 25 s
  3. 🫏 CNN 11 s

📻 On the radio

hourly newscasts that carried it, by show; beside the count, how often it was the lead story, or the highest it came in the running order

  1. 🫏 NPR News Now 4× · best #3

🎙️ On the shows

podcasts, newsletters and streams that talked about it, by show; the bar is episodes; the disc is the show's lean by reputation

  1. 🫏 MeidasTouch 1

🕵️ Investigated, joked about

🕵️ investigative reporting on it and 🃏 satire joking about it (jokes, never counted as coverage); the bar is pieces

🕵️🤷 No investigator or satirist matched to it yet.

🧶 Retelling

what people online made of it

🧶 Retold online

  • The FDA is requiring GLP-1 drugs to carry warnings about a rare risk of permanent vision loss. Nov 10: told by 11 people

On Folklore: the latest in full, with their motifs and who is telling them.

🗣️ Names in it

FDAGLP-1 drugsOzempicZepbound

🔎 Checking

what the fact-checkers looked into

🧐 No fact-checker has taken it on yet.

🧵 Persistence

the running story it belongs to

🌱 A story of its own so far: no saga yet.